EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy of 1064‐Nm Picosecond Nd: YAG Laser in Treating Facial Photoaging and Improving Skin Barrier Enhanced by a Multi‐Beneficial Composition Formulation: A Blinded Randomized Clinical Trial Study

Yixuan He iD, Manru Ning iD, Feifei Wang iD, Yihuai Liang iD, Shuxian Yan iD

Journal of Cosmetic Dermatology · 2026-05 · 25 (5)

DOI: 10.1111/jocd.70886 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 05.05.2026. Verfasst von Yixuan He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sino United Health, Shanghai, China. Hauptthemen laut MEDLINE: Skin Aging, Lasers, Solid-State, Low-Level Light Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Characteristic Plant Extraction Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In recent years, skin photoaging has received increasing attention, and laser therapy has become the most commonly used treatment due to its safety and efficacy; emerging evidence suggests that adjunctive “integrated skincare” may enhance treatment benefits by reducing post‐procedural reactions and supporting skin barrier repair.

Objective

The split‐face, double‐blind, randomized, placebo‐controlled, monocentric clinical trial was conducted to validate the potential efficacy of anti‐photoaging and skin repair of a multifunctional serum formulation following a one‐session therapy of 1064‐nm picosecond Nd:YAG laser.

Methods

A total of twenty‐four participants requesting picosecond laser therapy to address age‐associated facial alterations were recruited for the study. Following a two‐week washout period, participants underwent a single laser session on Day 1 (T1d) and applied either the multi‐beneficial serum or the placebo to the designated facial side twice daily for eight weeks. Their facial skin manifestations were assessed by two dermatologists at baseline, T0, T15d, T29d, and T57d, and the Symptom Score Reduction Index (SSRI) was analyzed later. Non‐invasive measurements and self‐assessments were also administered at each visit.

Results

Twenty‐four women aged 30–48 years completed the trial. The scores for all other manifestations of skin photoaging, with the exception of coarse wrinkles, decreased on both the test and control sides throughout follow‐up. Based on SSRI values for individual photoaging signs, clinical efficacy rates for the test sides were superior to their counterparts. Regarding skin barrier function, decreasing transepidermal water loss and increasing stratum corneum hydration were observed on the test side during the period of recovery, with significant intergroup differences on T29d and T57d. Skin tone indicators (erythema index, melanin index, and tone evenness) rose shortly after the laser treatment and then declined on both sides; the magnitudes of reductions were greater on the test sides than on the control ones. Even though the improvement of skin surface evenness was found due to the therapy, the test sides exhibited more favorable changes than the controls, for instance, a reduction in the area proportion of crow's feet. No adverse events related to the test product were found during the study.

Conclusion

The test serum enhanced the efficacy of 1064‐nm picosecond laser treatment for facial photoaging and supported skin barrier recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin AgingLasers, Solid-StateLow-Level Light TherapyHumansFemaleDouble-Blind MethodMiddle AgedAdultFaceTreatment OutcomeSkinWater Loss, Insensible

Stichwörter der Autor:innen

1064‐nm picosecond laserphotoagingskin physiology

Autor:innen und Institutionen

  • Sino United Health, Shanghai, China.
  • Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Kunming, Yunnan, China.
  • Yunnan Botanee Bio-Technology Group Co., Ltd., Kunming, Yunnan, China.

ORCID-Profile: Yixuan He, Manru Ning, Feifei Wang, Yihuai Liang, Shuxian Yan

Förderung

  • Yunnan Characteristic Plant Extraction Laboratory

Zitieren

APA

He, Y., Ning, M., Wang, F., Liang, Y., & Yan, S. (2026). Efficacy of 1064‐Nm Picosecond Nd: YAG Laser in Treating Facial Photoaging and Improving Skin Barrier Enhanced by a Multi‐Beneficial Composition Formulation: A Blinded Randomized Clinical Trial Study. Journal of Cosmetic Dermatology, 25(5). https://doi.org/10.1111/jocd.70886

Vancouver

He Y, Ning M, Wang F, Liang Y, Yan S. Efficacy of 1064‐Nm Picosecond Nd: YAG Laser in Treating Facial Photoaging and Improving Skin Barrier Enhanced by a Multi‐Beneficial Composition Formulation: A Blinded Randomized Clinical Trial Study. Journal of Cosmetic Dermatology. 2026;25(5). doi:10.1111/jocd.70886

BibTeX
@article{He2026,
  author = {He, Yixuan and Ning, Manru and Wang, Feifei and Liang, Yihuai and Yan, Shuxian},
  title = {Efficacy of 1064‐Nm Picosecond Nd: YAG Laser in Treating Facial Photoaging and Improving Skin Barrier Enhanced by a Multi‐Beneficial Composition Formulation: A Blinded Randomized Clinical Trial Study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  volume = {25},
  number = {5},
  doi = {10.1111/jocd.70886}
}
Kostenlos starten →